2022

1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

   Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

2. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

   Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461